Skip to main content
Log in

Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study

  • Nephrology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Introduction

The number of patients with end-stage renal disease (ESRD) due to diabetic nephropathy (DN) is increasing worldwide. In many countries, diabetes mellitus has become the most frequent cause of ESRD. The goal of this work is to critically evaluate the prevalence of DN among chronic regular hemodialysis (HD) patients in El-Minia Governorate, to evaluate changes over the course of 5 years, and to compare data of El-Minia Governorate with data from the United States and other countries, in an attempt to detect factors that might explain causes of the differences.

Material and methods

Data of patients on HD enrolled in the annual registry of the causes of ESRD in El-Minia Governorate were evaluated during the period from 2004 to 2008 for prevalence of DN. ESRD related to diabetes was defined as people who were initiated on chronic regular HD with diabetes mellitus as the cause of ESRD.

Results

The prevalence of DN among HD patients increased from 5% in 2004 to 16% in 2008. The mean age was significantly higher than that of ESRD patients on HD due to other etiologies. Furthermore, DN was more prevalent in urban areas than rural areas.

Conclusion

Diabetic nephropathy among HD patients in El-Minia Governorate is increasing but is less prevalent than in the United States and other Western countries, probably because of a higher incidence of other causes of ESRD in El-Minia governorate, or because of premature death of diabetic patients. Therefore, meticulous management of diabetic patients is mandatory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Panzetta G, Basile C, Santoro A et al (2008) Diabetics on dialysis in Italy: a nationwide epidemiological study. Nephrol Dial Transpl 23:3988–3995

    Article  Google Scholar 

  2. Woredekal Y (2008) Early detection and treatment of diabetic nephropathy. Pediatr Endocrinol Rev 5:999–1004

    PubMed  Google Scholar 

  3. Kalantar-Zadeh K, Derose SF, Nicholas S et al (2009) Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. J Ren Nutr 19:33–37

    Article  PubMed  Google Scholar 

  4. Earle KA, Porter KK, Ostberg J et al (2001) Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial Transplant 16:286–290

    Article  PubMed  CAS  Google Scholar 

  5. Halimi S, Zmirou D, Benhamou PY et al (1999) Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study). Diabetes Metab 25:507–512

    PubMed  CAS  Google Scholar 

  6. Hollenberg NK (2001) Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Curr Hypertens Rep 3:177

    Article  PubMed  CAS  Google Scholar 

  7. Afifi A, Karim MA (1999) Renal replacement therapy in Egypt: first annual report of the Egyptian Society of Nephrology. East Mediterr Health J 5:1023–1029

    PubMed  CAS  Google Scholar 

  8. Afifi A, El Setouhy M, El Sharkawy M et al (2004) Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study. East Mediterr Heath J 10:1–7

    Google Scholar 

  9. El-Minshawy O, El-Sharqawy M, Ewais E (2002) End stage renal disease in El-Minia Governorate (Central Egypt): an epidemiological study. J Egypt Soc Nephrol 4:34–41

    Google Scholar 

  10. El-Minshawy O, Kamel EG (2006) Renal replacement therapy and increased risk of cardiovascular disease in El-Minia Governorate, Upper Egypt. Egypt J Hosp Med 22:20–38

    Google Scholar 

  11. Lim YN, Lim TO, Lee DG et al (2008) Report of the Malaysian dialysis registry of the National Renal Registry, Malaysia. Med J Malaya 63:5–8

    PubMed  Google Scholar 

  12. Nakai S, Masakane I, Akiba T (2008) Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial 126:428–456

    Article  Google Scholar 

  13. US Renal Data System (2007) USRDS 2006 Annual Data Report: Atlas of End Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD

  14. Agarwal SK, Srivastava RK (2009) Chronic kidney disease in India: challenges and solutions. Nephron Clin Pract 111:c197–c203

    Article  PubMed  CAS  Google Scholar 

  15. Pérez-García R, Martín-Malo A, Fort J (2009) ANSWER study: baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER—a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 24:578–588

    Article  PubMed  Google Scholar 

  16. Barsoum R (2003) End-stage renal disease in North Africa. Kidney Int Suppl 83:111–114

    Article  Google Scholar 

  17. Moukeh G, Yacoub R, Fahdi F (2009) Epidemiology of hemodialysis patients in Aleppo city. Saudi J Kidney Dis Transpl 20:140–146

    PubMed  Google Scholar 

  18. Khanfri N, Medkouri G, Aghai R (2005) Diabetic nephropathy in hemodialysis patients in Casablanca. Saudi J Kidney Dis Transpl 16:89–92

    PubMed  CAS  Google Scholar 

  19. Alebiosu CO, Ayodele OE (2006) The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria. Trop Doct 36:218–219

    Article  PubMed  CAS  Google Scholar 

  20. Bergrem H, Leivestad T (2001) Diabetic nephropathy and end-stage renal failure: the Norwegian story. Adv Ren Replace Ther 8:4–12

    Article  PubMed  CAS  Google Scholar 

  21. Arab M (1992) Diabetes mellitus in Egypt. World Health Stat Q 45:334–337

    PubMed  CAS  Google Scholar 

  22. Harman WH (1995) Diabetes mellitus in Egypt: risk factors and prevalence. Diabet Med 12:1126–1131

    Article  Google Scholar 

  23. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431

    Article  PubMed  CAS  Google Scholar 

  24. Speakman JR (2008) Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective the ‘drifty gene’ hypothesis. Int J Obes (Lond) 32(11):1611–1617

    Article  CAS  Google Scholar 

  25. Nair L, Nair MK, Chacko DS (2009) Markers of fetal onset adult diseases. Indian Pediatr 46(Suppl):s48–s54

    PubMed  Google Scholar 

  26. Bhopal RS, Rafnsson SB (2009) Could mitochondrial efficiency explain the susceptibility to adiposity, metabolic syndrome, diabetes and cardiovascular diseases in South Asian populations? Int J Epidemiol 38(4):1072–1081

    Article  PubMed  Google Scholar 

  27. Stack AG, Bloembergen WE (2001) Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 12:1516–1523

    PubMed  CAS  Google Scholar 

  28. Eggers PW, Gohdes D, Pugh J (1999) Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 56:1524–1533

    Article  PubMed  CAS  Google Scholar 

  29. Schomig M, Ritz E, Standl E (2000) The diabetic foot in the dialyzed patient. J Am Soc Nephrol 11:1153–1159

    PubMed  CAS  Google Scholar 

  30. Herzog CA, Ma JZ, Collins AJ (1998) Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339:799–805

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Osama El-Minshawy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El-Minshawy, O., Kamel, E.G. Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study. Int Urol Nephrol 43, 507–512 (2011). https://doi.org/10.1007/s11255-010-9713-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-010-9713-z

Keywords

Navigation